Picard Medical (AMEX:PMI) reported quarterly losses of $(3.05) per share which missed the analyst consensus estimate of $(1.50) by 103.33 percent. This is a 92.8 percent increase over losses of $(42.39) per share from the same period last year. The company reported quarterly sales of $2.954 million which beat the analyst consensus estimate of $1.550 million by 90.58 percent. This is a 38.62 percent increase over sales of $2.131 million the same period last year.